Which medications are safe for treating allergic rhinitis in a pregnant woman?

Safe Allergy Medications for Pregnant Women

Intranasal corticosteroids (particularly budesonide) and second-generation antihistamines (cetirizine or loratadine) are the safest and most effective first-line treatments for allergic rhinitis during pregnancy. 1

First-Line Treatment Options

Intranasal Corticosteroids (Preferred)

• Intranasal corticosteroids are safe and effective throughout pregnancy and should be considered first-line therapy due to their superior efficacy and minimal systemic absorption 1
• Budesonide is the preferred intranasal corticosteroid as it has the most extensive human safety data and is classified as Pregnancy Category B 1
• Other safe options include beclomethasone, fluticasone propionate, and mometasone, all showing no convincing evidence of congenital defects 1, 2
• Meta-analyses confirm no increased risks of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension with intranasal corticosteroids 1
• Use the lowest effective dose to maintain symptom control 1

Second-Generation Antihistamines

• Cetirizine and loratadine are the preferred oral antihistamines with the most robust safety data during pregnancy 1, 3, 4
• Loratadine has been studied in over 2,000 pregnant women with no increased teratogenic risk 4
• Cetirizine exposure in 228 pregnancies showed 83.7% live births with only 2 congenital malformations, consistent with background rates 5
• Second-generation antihistamines have comparable safety profiles to first-generation agents but without sedative and anticholinergic side effects 1

Additional Safe Options

Nasal Saline and Cromolyn

• Saline nasal rinses are safe throughout pregnancy and should be recommended as adjunctive therapy 1
• Sodium cromolyn (Pregnancy Category B) is safe but requires frequent dosing (4 times daily) and has limited efficacy compared to intranasal corticosteroids 1, 4

Montelukast (Leukotriene Receptor Antagonist)

• Montelukast (Pregnancy Category B) can be used if there was favorable pre-pregnancy response, particularly in patients with concurrent asthma 1
• Limited data from 9 patients showed no adverse events, though more extensive studies are needed 1
• Should not be first-line for rhinitis alone but reasonable to continue if already effective 1

Allergen Immunotherapy

• Continue immunotherapy if already initiated pre-pregnancy without dose escalation 1
• Do not start new immunotherapy or increase doses during pregnancy due to anaphylaxis risk 1

Medications to AVOID

Oral Decongestants (Avoid First Trimester)

• Oral decongestants (phenylephrine, pseudoephedrine) should be avoided during the first trimester due to associations with gastroschisis, small intestinal atresia, and cardiac abnormalities 1, 6
• Risk increases when combined with acetaminophen or salicylates 1
• May also contribute to maternal hypertension 1

First-Generation Antihistamines (Use Cautiously)

• Diphenhydramine has been associated with cleft palate development in some studies, though recent data are more reassuring 1
• Hydroxyzine should be avoided in the first trimester based on animal data 1
• First-generation antihistamines should generally be avoided due to sedative and anticholinergic properties 1

Intranasal Antihistamines

• Avoid intranasal antihistamines (azelastine) during pregnancy due to limited safety data 1, 3

Treatment Algorithm by Severity

Mild Intermittent Symptoms

• Start with saline nasal rinses 1
• Add cetirizine or loratadine as needed 1, 3, 4

Mild to Moderate Persistent Symptoms

• Intranasal budesonide as first-line 1
• Add cetirizine or loratadine if inadequate response 1
• Consider sodium cromolyn if patient prefers non-steroid option 1, 4

Moderate to Severe Persistent Symptoms

• Intranasal corticosteroid (budesonide preferred) plus oral antihistamine 1
• Add montelukast if concurrent asthma or prior favorable response 1

Severe Exacerbations

• Short-course oral corticosteroids may be used after the first trimester if benefits outweigh risks, particularly with concurrent asthma exacerbation 1
• Consult with patient's obstetrician before initiating 1

Critical Caveats

Timing matters: First trimester is the period of greatest concern for teratogenicity during organogenesis 1. Oral decongestants and hydroxyzine should be strictly avoided during this period 1.

FDA pregnancy categories are based largely on animal studies with limited human data, so review actual human cohort studies and registry data when available 1.

Combination products containing decongestants with acetaminophen or salicylates carry higher malformation risks and should be avoided 1.

Human safety data consistently support intranasal corticosteroids and select second-generation antihistamines as the safest, most effective options throughout pregnancy 1, 4.